Display options
Cite
Aghahowa SE, Ozolua RI, Bafor EE, et al. Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients. Toxicol Rep. 2021;8:1930-1936doi: 10.1016/j.toxrep.2021.11.007.
Aghahowa, S. E., Ozolua, R. I., Bafor, E. E., Obarisiagbon, P., & Isah, A. O. (2021). Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients. Toxicology reports, 81930-1936. https://doi.org/10.1016/j.toxrep.2021.11.007
Aghahowa, S E, et al. "Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients." Toxicology reports vol. 8 (2021): 1930-1936. doi: https://doi.org/10.1016/j.toxrep.2021.11.007
Aghahowa SE, Ozolua RI, Bafor EE, Obarisiagbon P, Isah AO. Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients. Toxicol Rep. 2021 Nov 25;8:1930-1936. doi: 10.1016/j.toxrep.2021.11.007. eCollection 2021. PMID: 34926171; PMCID: PMC8649067.
Copy Download .nbib Format: NLM
Share it on

Toxicol Rep. 2021 Nov 25;8:1930-1936. doi: 10.1016/j.toxrep.2021.11.007. eCollection 2021.

Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients.

Toxicology reports

S E Aghahowa, R I Ozolua, E E Bafor, P Obarisiagbon, A O Isah

Affiliations

  1. Department of Pharmacology and Toxicology, University of Benin, Benin City, Nigeria.
  2. College of Medicine, University of Benin, Benin City, Nigeria.

PMID: 34926171 PMCID: PMC8649067 DOI: 10.1016/j.toxrep.2021.11.007

Abstract

BACKGROUND: Following the paucity of safety reports in the use of Artemisinin-Based Combination Therapies (ACTs) plus paracetamol, the study assessed safety potential of artemether-lumefantrine (ALP), artesunate-amodiaquine (AAP), artesunate-mefloquine (AMP), artesunate-sulphadoxine-pyrimethamine (ASPP) and dihydroartemisinin-piperaquine (DHPP) combination with paracetamol in malaria patients.

METHODS: ACTs and paracetamol were administered concomitantly in conventional doses/regimen to randomly selected patients. Blood samples were collected from the ante-cubital vein before and after completion of therapies. Toxicity markers such as weights, glucose, lipids, renal electrolytes, liver enzymes and haematological indices were assessed using standard protocols.

RESULTS: The total numbers of participants were 57 patients. Male to female ratio was 1:1.1. Mean body weight and ages were 59.19 ± 1.39 kg and 42.86 ± 1.32 years respectively. The mean temperatures prior to and after therapy were 37.49 ± 1.02 °C and 37.50 ± 0.17 °C respectively. Mean parasitaemia before the commencement of therapy was 6282 ± 21.01 parasites/μl. Out of thirty-seven toxicological indices evaluated, twenty-four were significantly altered by ACTs plus paracetamol (

CONCLUSION: Since ACTs plus paracetamol altered human system, discrete selection is essential in managing uncomplicated malaria most especially in patients with co-morbid conditions.

© 2021 The Author(s).

Keywords: ACTs; Malaria; Paracetamol; Safety

Conflict of interest statement

The authors report no declarations of interest.

Publication Types